From January 1, 2022 to March 31, 2022, the company has repurchased 0 shares, representing 0% for $0 million. With this, the company has completed the repurchase of 648,844 shares, representing 2.17% for $226.91 million under the buyback announced on November 28, 2017.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
275.9 USD | +0.12% | -1.35% | -14.54% |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-14.54% | 7.88B | |
-2.31% | 185B | |
-3.20% | 105B | |
-5.04% | 66.59B | |
+0.20% | 54.66B | |
+17.29% | 47.78B | |
+4.06% | 41.26B | |
+2.36% | 26.95B | |
+2.07% | 26.37B | |
+12.96% | 24.8B |
- Stock Market
- Equities
- BIO Stock
- News Bio-Rad Laboratories, Inc.
- Tranche Update on Bio-Rad Laboratories, Inc.'s Equity Buyback Plan announced on November 28, 2017.